LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:----------FTSE 100----------MERRILL LYNCH CUTS VODAFONE TO 'NEUTRAL' (BUY) - PRICE TARGET 202 (260) PENCE----------LIBERUM CUTS GLAXOSMITHKLINE TO 'HOLD' ('BUY')----------CREDIT SUISSE RAISES ASTRAZENECA PRICE TARGET TO 6350 (5900) PENCE - 'OUTPERFORM'----------EXANE BNP CUTS BUNZL TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2425 PENCE ----------CREDIT SUISSE RAISES BUNZL PRICE TARGET TO 2600 (2470) PENCE - 'OUTPERFORM'----------BERENBERG RAISES PRUDENTIAL PRICE TARGET TO 2600 (2400) PENCE - 'BUY'----------DEUTSCHE BANK CUTS AB FOODS PRICE TARGET TO 3000 (3100) PENCE - 'BUY'----------DEUTSCHE BANK CUTS TAYLOR WIMPEY PRICE TARGET TO 237 (244) PENCE - 'BUY'----------DEUTSCHE BANK CUTS PERSIMMON PRICE TARGET TO 3053 (3093) PENCE - 'HOLD'----------DEUTSCHE BANK RAISES BERKELEY GROUP PRICE TARGET TO 4095 (4014) PENCE - 'HOLD'----------DEUTSCHE BANK CUTS BARRATT DEVELOPMENTS PRICE TARGET TO 792 (794) PENCE - 'BUY'----------FTSE 250----------DEUTSCHE BANK RAISES BELLWAY TO 'BUY' ('HOLD') - TARGET 3745 (3716) PENCE----------RBC CUTS IWG TO 'UNDERPERFORM' ('SECTOR PERFORM') - TARGET 200 (220) PENCE----------MORGAN STANLEY RAISES UNITE GROUP TO 'OVERWEIGHT' ('EQUAL-WEIGHT') - TARGET 930 (850) PENCE----------MORGAN STANLEY CUTS INTU PROPERTIES TO 'UNDERWEIGHT' (EQUAL-WEIGHT) - TARGET 150 (190) PENCE----------MORGAN STANLEY RAISES PETROFAC TO 'EQUAL-WEIGHT' ('UNDERWEIGHT') - TARGET 800 (650) PENCE----------SOCGEN RAISES PETROFAC PRICE TARGET TO 791 (719) PENCE - 'BUY'----------KEPLER CHEUVREUX RAISES PETROFAC PRICE TARGET TO 700 (660) PENCE - 'HOLD' ----------LIBERUM RAISES HOMESERVE PRICE TARGET TO 1120 (950) PENCE - 'BUY'----------DEUTSCHE BANK CUTS REDROW PRICE TARGET TO 622 (672) PENCE - 'HOLD'----------DEUTSCHE BANK RAISES MCCARTHY & STONE PRICE TARGET TO 168 (165) PENCE - 'BUY'----------DEUTSCHE BANK CUTS CREST NICHOLSON PRICE TARGET TO 506 (524) PENCE - 'HOLD'----------RBC RAISES DIPLOMA PRICE TARGET TO 1280 (1130) PENCE - 'SECTOR PERFORM'----------OTHER MAIN MARKET AND AIM----------NUMIS RAISES FORTERRA TO 'BUY' ('ADD') - TARGET 365 PENCE----------NUMIS CUTS AMIGO HOLDINGS TO 'ADD' ('BUY') - TARGET 330 PENCE----------BERENBERG INITIATES SUMO GROUP WITH 'BUY' - TARGET 205 PENCE----------BERENBERG RAISES DALATA HOTEL PRICE TARGET TO 700 (660) PENCE - 'BUY'----------BERENBERG RAISES GYM GROUP PRICE TARGET TO 370 (320) PENCE - 'BUY'----------
Fate of most remaining Zantac lawsuits weighed by Delaware judge
Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.
Read more